Wet AMD Market Set for Robust Growth Through 2036, Driven by Advancements in Anti-VEGF Therapies | DelveInsight

Recently published Wet AMD Market Insights report includes a comprehensive understanding of current treatment practices, wet ...
Healio

Home OCT a ‘safety net’ for reducing treatment burden in wet AMD

Please provide your email address to receive an email when new articles are posted on . Home OCT may help patients achieve extended dosing intervals through consistent fluid evaluation. Scans are ...
Healio

Physicians consider benefits, pitfalls of at-home monitoring for wet AMD

Please provide your email address to receive an email when new articles are posted on . One presenter said at-home OCT has the potential to improve outcomes in neovascular AMD through personalized ...
Nasdaq

Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting

ALPHARETTA, Ga., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
Nasdaq

Keep An Eye On EYPT - Diabetic Macular Edema, Wet AMD Trial Results Awaited

(RTTNews) - EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last October, expects to report full topline results in the first ...
MedPage Today

Ophthalmologists or AI: Who’s Better Equipped to Predict Progression in Geographic Atrophy?

—With a greater number of treatments available for age-related macular degeneration (AMD), it’s more important than ever that patients’ progression of geographic atrophy (GA) secondary to AMD is ...

DelveInsight Business Research, LLP: Wet AMD Market Set for Robust Growth Through 2036, Driven by Advancements in Anti-VEGF Therapies | DelveInsight

The wet AMD market is expected to grow due to the increasing diagnosed cases of Wet-AMD, the current therapies, and the launch of emerging therapies such as Ixoberogene soroparvovec (Ixo-vec) ...